Search research articles
Contact Us
Filters
Showing results (41-50 of 127) with videos related to
Page
of 13
Sort By:
Haematologica
|
February 16, 2019
Quantitative dynamic <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma
Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, et al.
EJNMMI Research
|
October 10, 2021
The prognostic significance of [<sup>18</sup>F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, et al.
BMC Cancer
|
August 17, 2018
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
Seyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, et al.
Blood Cancer Journal
|
November 13, 2019
EASIX for prediction of survival in lower-risk myelodysplastic syndromes
Almuth Merz, Ulrich Germing, Guido Kobbe, et al.
Cancers
|
August 10, 2024
Calcium-Based Imaging of the Spine at Dual-Layer CT and Evaluation of Vertebral Fractures in Multiple Myeloma
Simone C Brandelik, Stefanie Rahn, Maximilian Merz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Biomedicines
|
August 29, 2024
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment
Anja Grahnert, Sabine Seiffert, Kerstin Wenk, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Oncotarget
|
October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial
Jonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
NPJ Digital Medicine
|
April 30, 2025
Predicting progression events in multiple myeloma from routine blood work
Maximilian Ferle, Nora Grieb, Markus Kreuz, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 127) with videos related to
Sort By:
Page
of 13
Haematologica
|
February 16, 2019
Quantitative dynamic <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma
Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, et al.
EJNMMI Research
|
October 10, 2021
The prognostic significance of [<sup>18</sup>F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, et al.
BMC Cancer
|
August 17, 2018
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
Seyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, et al.
Blood Cancer Journal
|
November 13, 2019
EASIX for prediction of survival in lower-risk myelodysplastic syndromes
Almuth Merz, Ulrich Germing, Guido Kobbe, et al.
Cancers
|
August 10, 2024
Calcium-Based Imaging of the Spine at Dual-Layer CT and Evaluation of Vertebral Fractures in Multiple Myeloma
Simone C Brandelik, Stefanie Rahn, Maximilian Merz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Biomedicines
|
August 29, 2024
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment
Anja Grahnert, Sabine Seiffert, Kerstin Wenk, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Oncotarget
|
October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial
Jonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
NPJ Digital Medicine
|
April 30, 2025
Predicting progression events in multiple myeloma from routine blood work
Maximilian Ferle, Nora Grieb, Markus Kreuz, et al.
Page
of 13